Author
Listed:
- Lanying Du
(Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center)
- Wanbo Tai
(Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology)
- Yang Yang
(University of Minnesota Medical School)
- Guangyu Zhao
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology)
- Qing Zhu
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology)
- Shihui Sun
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology)
- Chang Liu
(University of Minnesota Medical School)
- Xinrong Tao
(University of Texas Medical Branch)
- Chien-Te K. Tseng
(University of Texas Medical Branch)
- Stanley Perlman
(University of Iowa)
- Shibo Jiang
(Laboratory of Viral Immunology, Lindsley F. Kimball Research Institute, New York Blood Center
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University)
- Yusen Zhou
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology)
- Fang Li
(University of Minnesota Medical School)
Abstract
Viral subunit vaccines often contain immunodominant non-neutralizing epitopes that divert host immune responses. These epitopes should be eliminated in vaccine design, but there is no reliable method for evaluating an epitope’s capacity to elicit neutralizing immune responses. Here we introduce a new concept ‘neutralizing immunogenicity index’ (NII) to evaluate an epitope’s neutralizing immunogenicity. To determine the NII, we mask the epitope with a glycan probe and then assess the epitope’s contribution to the vaccine’s overall neutralizing immunogenicity. As proof-of-concept, we measure the NII for different epitopes on an immunogen comprised of the receptor-binding domain from MERS coronavirus (MERS-CoV). Further, we design a variant form of this vaccine by masking an epitope that has a negative NII score. This engineered vaccine demonstrates significantly enhanced efficacy in protecting transgenic mice from lethal MERS-CoV challenge. Our study may guide the rational design of highly effective subunit vaccines to combat MERS-CoV and other life-threatening viruses.
Suggested Citation
Lanying Du & Wanbo Tai & Yang Yang & Guangyu Zhao & Qing Zhu & Shihui Sun & Chang Liu & Xinrong Tao & Chien-Te K. Tseng & Stanley Perlman & Shibo Jiang & Yusen Zhou & Fang Li, 2016.
"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines,"
Nature Communications, Nature, vol. 7(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13473
DOI: 10.1038/ncomms13473
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13473. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.